Ageing research reviewsHumansGene EditingNeurodegenerative DiseasesCRISPR-Cas SystemsAnimals
CRISPR/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects.
Kalpana Pandya, Devendra Kumar
Published: 202610.1016/j.arr.2025.102922
Abstract
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), Spinocerebral Ataxia (SCA), and Huntington's disease (HD) are major global health challenges. Current treatments are only symp…
Preview only. Read the full abstract at the source